Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CTX130 |
Trade Name | |
Synonyms | CTX 130|CTX-130 |
Drug Descriptions |
CTX130 are allogeneic T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD70, which recognize and bind to CD70-expressing tumor cells, potentially resulting in antitumor activity (Cancer Res 2020;80 (16 Suppl):Abstract nr 6595). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C173153 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CTX130 | CTX130 | 0 | 2 |